Helixmith Announces Poster Presentations at the 2021 American Academy of Pain Medicine Meeting
News provided by
Share this article
Share this article
LA JOLLA, Calif., April 23, 2021 /PRNewswire/ Helixmith, a gene therapy company, announced today that three abstracts have been accepted for poster presentations at the virtual 2021 American Academy of Pain Medicine Annual Meeting to be held April 23 – 25, 2021.
Details of the poster presentations are as follows:
Title: Gene Therapy for Diabetic Peripheral Neuropathy: A Phase 3 study of VM202, a plasmid DNA encoding human hepatocyte growth factor
Helixmith Announces Poster Presentations at the 2021 American Academy of Pain Medicine Meeting